Tatsuya Shimizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tatsuya Shimizu has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Yuhei Yoshimoto
Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
10 shared publicationsMasanori Aihara
Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
5 shared publications- Masanori Aihara
Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan
5 shared publications Rei Yamaguchi
Department of Neurosurgery and Gunma University Graduate School of Medicine, Maebashi, Gunma
5 shared publicationsKaoru Aishima
Department of Neurosurgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan
4 shared publications- Hirofumi Asano
Department of Neurosurgery and Gunma University Graduate School of Medicine, Maebashi, Gunma
3 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (7)
Impact of endoscopy and related technologies on indications for transsphenoidal pituitary surgery for growth hormone–producing pituitary neuroendocrine tumors in McCune-Albright syndrome: illustrative case
BACKGROUND: McCune-Albright syndrome (MAS) is frequently associated with growth hormone (GH)–producing pituitary neuroendocrine tumors. However, transsphenoidal surgery is considered difficult because of skull base fibrous dysplasia, making complete tumor removal and endocrine remission challenging. OBSERVATIONS: Eighteen years earlier, a 31-year-old woman was diagnosed with MAS based on findings of GH hypersecretion, a café-au-lait spot on the back of her right shoulder, and bone lesions in the ribs and craniofacial bones. She had a pituitary tumor, but craniofacial fibrous dysplasia involving the sphenoid bone contraindicated surgical removal of the GH-producing pituitary tumor. Medical treatment was prioritized, and she underwent triple-drug therapy (octreotide, cabergoline, and pegvisomant) for 18 years. Insulin-like growth factor–1 remained poorly controlled. Recent advances in endonasal endoscopic surgery prompted reconsideration of surgical treatment. Endoscopic transnasal pituitary tumor resection using neuronavigation and a high-speed drill was performed, and achieved complete tumor resection, and all medical therapy became unnecessary. LESSONS: Surgical treatment was previously considered difficult in cases of GH-producing pituitary tumor associated with MAS. However, recent advances in transnasal endoscopic surgery, including drilling and neuronavigation techniques, have made surgical endocrine remission achievable in some cases. Therefore, surgical indications should be reconsidered even in patients undergoing medical therapy. https://thejns.org/doi/10.3171/CASE26521
- 17 August 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (7)
Open AccessImpact of endoscopy and related technologies on indications for transsphenoidal pituitary surgery for growth hormone–producing pituitary neuroendocrine tumors in McCune-Albright syndrome: illustrative case
BACKGROUND: McCune-Albright syndrome (MAS) is frequently associated with growth hormone (GH)–producing pituitary neuroendocrine tumors. However, transsphenoidal surgery is considered difficult because of skull base fibrous dysplasia, making complete tumor removal and endocrine remission challenging. OBSERVATIONS: Eighteen years earlier, a 31-year-old woman was diagnosed with MAS based on findings of GH hypersecretion, a café-au-lait spot on the back of her right shoulder, and bone lesions in the ribs and craniofacial bones. She had a pituitary tumor, but craniofacial fibrous dysplasia involving the sphenoid bone contraindicated surgical removal of the GH-producing pituitary tumor. Medical treatment was prioritized, and she underwent triple-drug therapy (octreotide, cabergoline, and pegvisomant) for 18 years. Insulin-like growth factor–1 remained poorly controlled. Recent advances in endonasal endoscopic surgery prompted reconsideration of surgical treatment. Endoscopic transnasal pituitary tumor resection using neuronavigation and a high-speed drill was performed, and achieved complete tumor resection, and all medical therapy became unnecessary. LESSONS: Surgical treatment was previously considered difficult in cases of GH-producing pituitary tumor associated with MAS. However, recent advances in transnasal endoscopic surgery, including drilling and neuronavigation techniques, have made surgical endocrine remission achievable in some cases. Therefore, surgical indications should be reconsidered even in patients undergoing medical therapy. https://thejns.org/doi/10.3171/CASE26521
- Open Access
- 3 August 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (5)
Ruptured artery of Percheron aneurysm in moyamoya disease with thalamic hemorrhage and acute hydrocephalus: illustrative case
BACKGROUND: In moyamoya disease, fragile collateral networks such as periventricular anastomoses are associated with an increased risk of hemorrhage, particularly in the posterior circulation. Peripheral aneurysms arising from these vessels are rare, and those involving the artery of Percheron are exceptionally uncommon. OBSERVATIONS: A 55-year-old patient with a history of thalamic hemorrhage presented with headache and impaired consciousness. CT revealed a right thalamic hemorrhage with intraventricular extension and acute hydrocephalus. Emergency ventricular drainage was performed. Subsequent angiography identified a ruptured peripheral aneurysm arising from the artery of Percheron originating from the left P1 segment, along with right-dominant moyamoya vascular architecture. The aneurysm was successfully treated with N -butyl cyanoacrylate embolization to prevent rebleeding. Due to insufficient clearance of intraventricular hematoma, endoscopic evacuation was performed. The patient experienced no rebleeding, and follow-up angiography confirmed durable obliteration of the aneurysm. LESSONS: Peripheral aneurysms arising from the artery of Percheron in moyamoya disease are extremely rare but should be considered in cases of deep hemorrhage with intraventricular extension. Prompt endovascular embolization using liquid embolic agents, combined with endoscopic hematoma evacuation, may provide an effective and minimally invasive treatment strategy. https://thejns.org/doi/10.3171/CASE26356
- 3 August 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (5)
Open AccessRuptured artery of Percheron aneurysm in moyamoya disease with thalamic hemorrhage and acute hydrocephalus: illustrative case
BACKGROUND: In moyamoya disease, fragile collateral networks such as periventricular anastomoses are associated with an increased risk of hemorrhage, particularly in the posterior circulation. Peripheral aneurysms arising from these vessels are rare, and those involving the artery of Percheron are exceptionally uncommon. OBSERVATIONS: A 55-year-old patient with a history of thalamic hemorrhage presented with headache and impaired consciousness. CT revealed a right thalamic hemorrhage with intraventricular extension and acute hydrocephalus. Emergency ventricular drainage was performed. Subsequent angiography identified a ruptured peripheral aneurysm arising from the artery of Percheron originating from the left P1 segment, along with right-dominant moyamoya vascular architecture. The aneurysm was successfully treated with N -butyl cyanoacrylate embolization to prevent rebleeding. Due to insufficient clearance of intraventricular hematoma, endoscopic evacuation was performed. The patient experienced no rebleeding, and follow-up angiography confirmed durable obliteration of the aneurysm. LESSONS: Peripheral aneurysms arising from the artery of Percheron in moyamoya disease are extremely rare but should be considered in cases of deep hemorrhage with intraventricular extension. Prompt endovascular embolization using liquid embolic agents, combined with endoscopic hematoma evacuation, may provide an effective and minimally invasive treatment strategy. https://thejns.org/doi/10.3171/CASE26356
- 5 April 2024
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 32 (4) , 1358-1364
Factors associated with decreasing diffusion-weighted imaging-positive area volume after mechanical thrombectomy in patients with large early ischemic changes
Objectives: This study aimed to evaluate the factors associated with decreasing diffusion-weighted imaging (DWI) positive areas in patients with large early ischemic changes after mechanical thrombectomy (MT). Materials and Methods: This retrospective single-center clinical study was conducted between January 2013 and December 2022. We included consecutive patients who underwent MT for acute large-vessel occlusion of the anterior circulation with low pretreatment DWI-Alberta Stroke Program Early Computed Tomography Scores (ASPECTS) (0–5), effective recanalization [thrombolysis in cerebral infarction (TICI) 2b or TICI3], and magnetic resonance imaging (MRI) acquired before and after MT. We measured the DWI-positive area volume before and after MT. The primary endpoint was the after/before-MT DWI-positive area–volume ratio. Results: In total, 28 patients were included in this study. Eight patients (29%) had an after/before-MT DWI-positive area–volume ratio of 2/s and 637 × 106 mm2/s, respectively ( p = 0.011). Multivariate logistic regression analysis showed that ADC level (OR, 1.020 [95% confidence intervals (CIs), 1.001–1.040]; p = 0.040) was an independent predictor of a decreased DWI-positive area after MT. There was a negative correlation between the mean ADC level and the after/before-MT DWI-positive area–volume ratio ( p < 0.001, | ρ| = 0.650), and the mean pretreatment ADC cutoff level was 649 × 106 mm2/s (area under the curve (AUC) = 0.806) for predicting a volume ratio of 6 mm2/s predicted a decreased DWI-positive area after MT.
- 5 April 2024
- Published by SAGE Publications in Interventional Neuroradiology
- Vol. 32 (4) , 1358-1364
Factors associated with decreasing diffusion-weighted imaging-positive area volume after mechanical thrombectomy in patients with large early ischemic changes
Objectives: This study aimed to evaluate the factors associated with decreasing diffusion-weighted imaging (DWI) positive areas in patients with large early ischemic changes after mechanical thrombectomy (MT). Materials and Methods: This retrospective single-center clinical study was conducted between January 2013 and December 2022. We included consecutive patients who underwent MT for acute large-vessel occlusion of the anterior circulation with low pretreatment DWI-Alberta Stroke Program Early Computed Tomography Scores (ASPECTS) (0–5), effective recanalization [thrombolysis in cerebral infarction (TICI) 2b or TICI3], and magnetic resonance imaging (MRI) acquired before and after MT. We measured the DWI-positive area volume before and after MT. The primary endpoint was the after/before-MT DWI-positive area–volume ratio. Results: In total, 28 patients were included in this study. Eight patients (29%) had an after/before-MT DWI-positive area–volume ratio of 2/s and 637 × 106 mm2/s, respectively ( p = 0.011). Multivariate logistic regression analysis showed that ADC level (OR, 1.020 [95% confidence intervals (CIs), 1.001–1.040]; p = 0.040) was an independent predictor of a decreased DWI-positive area after MT. There was a negative correlation between the mean ADC level and the after/before-MT DWI-positive area–volume ratio ( p < 0.001, | ρ| = 0.650), and the mean pretreatment ADC cutoff level was 649 × 106 mm2/s (area under the curve (AUC) = 0.806) for predicting a volume ratio of 6 mm2/s predicted a decreased DWI-positive area after MT.
- Open Access
- 16 June 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 208
Glossopharyngeal neuralgia with repeated cardiac syncope: A case report
Background: Glossopharyngeal neuralgia (GPN) is an uncommon craniofacial pain syndrome. Although rare, it is occasionally associated with cardiac syncope, as vago-glossopharyngeal neuralgia (VGPN). Case Description: We present the case of a 73-year-old man with VGPN misdiagnosed as trigeminal neuralgia. The patient was diagnosed with sick sinus syndrome, and a pacemaker was introduced. However, syncope still recurred. Magnetic resonance imaging revealed a branch of the right posterior inferior cerebellar artery contacting the root exit zone of the right glossopharyngeal and vagus nerves. We diagnosed VGPN due to neurovascular compression and performed microvascular decompression (MVD). The symptoms disappeared postoperatively. Conclusion: Diagnosis of VGPN needs appropriate medical interviews and physical examination. MVD is the only curative treatment for VGPN occurring as a neurovascular compression syndrome.
- 16 June 2023
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 208
Open AccessGlossopharyngeal neuralgia with repeated cardiac syncope: A case report
Background: Glossopharyngeal neuralgia (GPN) is an uncommon craniofacial pain syndrome. Although rare, it is occasionally associated with cardiac syncope, as vago-glossopharyngeal neuralgia (VGPN). Case Description: We present the case of a 73-year-old man with VGPN misdiagnosed as trigeminal neuralgia. The patient was diagnosed with sick sinus syndrome, and a pacemaker was introduced. However, syncope still recurred. Magnetic resonance imaging revealed a branch of the right posterior inferior cerebellar artery contacting the root exit zone of the right glossopharyngeal and vagus nerves. We diagnosed VGPN due to neurovascular compression and performed microvascular decompression (MVD). The symptoms disappeared postoperatively. Conclusion: Diagnosis of VGPN needs appropriate medical interviews and physical examination. MVD is the only curative treatment for VGPN occurring as a neurovascular compression syndrome.
- 11 April 2023
- Published by Elsevier in World Neurosurgery
- Vol. 175, e704-e712
The Significance of the Intercarotid Distances for Transsphenoidal Pituitary Surgery: A Magnetic Resonance Imaging Study
- 11 April 2023
- Published by Elsevier in World Neurosurgery
- Vol. 175, e704-e712
The Significance of the Intercarotid Distances for Transsphenoidal Pituitary Surgery: A Magnetic Resonance Imaging Study
- 4 April 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (6) , 107110
Impact of craniotomy area on improvement of cerebral blood flow in combined revascularization surgery for moyamoya disease
- 4 April 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (6) , 107110
Impact of craniotomy area on improvement of cerebral blood flow in combined revascularization surgery for moyamoya disease
- 8 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 163, e482-e492
Long-Term Durability and Recurrence Patterns After Endovascular Treatment for Basilar Tip Aneurysms
- 8 April 2022
- Published by Elsevier in World Neurosurgery
- Vol. 163, e482-e492
Long-Term Durability and Recurrence Patterns After Endovascular Treatment for Basilar Tip Aneurysms
- 1 January 2022
- Vol. 63 (1) , 55-61
[Refractory thrombotic thrombocytopenic purpura complicated with multiple cerebral infarction].
Neuropsychiatric symptoms comprise one of the five classic symptoms of autoimmune thrombotic thrombocytopenic purpura (aTTP). Although aTTP is typically transient, it is sometimes complicated by cerebral infarction with residual disability. This report presents the case of an 87-year-old man previously admitted to a different hospital with fever and transient consciousness loss. After receiving platelet transfusion with diagnosis of Evans syndrome, he was transferred to our hospital with worsening consciousness disturbance. He was subsequently diagnosed with aTTP with a PLASMIC score of 6 points, ADAMTS13 activity of less than 0.5%, and its inhibitor of 7.4 BU/ml. Platelet count and consciousness were rapidly improved with plasmapheresis and steroids, but motor aphasia emerged. MRI showed multiple cerebral infarctions, including a large infarction in the left frontal lobe. Thus, unfractionated heparin was administered. When his platelet count dropped once again on the 20th day, rituximab was added. The treatment eventually proved to be successful, and his aTTP remained in remission one year after the onset. Treatment for cerebral infarctions was switched to DOAC, and rehabilitation was continued. However, his ADL has not yet recovered. Advances in aTTP treatment have cured many similar cases. Thus, rituximab is now considered a treatment option for refractory cases. However, ischemic organ damage in acute phase and sequelae are observed. Therefore, early diagnosis and novel therapy are required.
- 1 January 2022
- Vol. 63 (1) , 55-61
[Refractory thrombotic thrombocytopenic purpura complicated with multiple cerebral infarction].
Neuropsychiatric symptoms comprise one of the five classic symptoms of autoimmune thrombotic thrombocytopenic purpura (aTTP). Although aTTP is typically transient, it is sometimes complicated by cerebral infarction with residual disability. This report presents the case of an 87-year-old man previously admitted to a different hospital with fever and transient consciousness loss. After receiving platelet transfusion with diagnosis of Evans syndrome, he was transferred to our hospital with worsening consciousness disturbance. He was subsequently diagnosed with aTTP with a PLASMIC score of 6 points, ADAMTS13 activity of less than 0.5%, and its inhibitor of 7.4 BU/ml. Platelet count and consciousness were rapidly improved with plasmapheresis and steroids, but motor aphasia emerged. MRI showed multiple cerebral infarctions, including a large infarction in the left frontal lobe. Thus, unfractionated heparin was administered. When his platelet count dropped once again on the 20th day, rituximab was added. The treatment eventually proved to be successful, and his aTTP remained in remission one year after the onset. Treatment for cerebral infarctions was switched to DOAC, and rehabilitation was continued. However, his ADL has not yet recovered. Advances in aTTP treatment have cured many similar cases. Thus, rituximab is now considered a treatment option for refractory cases. However, ischemic organ damage in acute phase and sequelae are observed. Therefore, early diagnosis and novel therapy are required.
- 1 April 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (4) , 105626
Acute Endovascular Revascularization for Patients with Common Carotid Artery Occlusion Apparent on Cervical Magnetic Resonance Angiography
- 1 April 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (4) , 105626
Acute Endovascular Revascularization for Patients with Common Carotid Artery Occlusion Apparent on Cervical Magnetic Resonance Angiography